Search Results

Displaying Results 1-2 of 2 "'AUTL'"

Dec 19, 2025, 07:44 ET Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

Inc. (NASDAQ: GTBP), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Genmab A/S (NASDAQ: GMAB), Autolus Therapeutics plc (NASDAQ: AUTL), and Lyell Immunopharma, Inc. (NASDAQ: LYEL).

More news about: USA News Group


Sep 15, 2025, 08:30 ET Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

Therapeutics Inc. (NASDAQ: SRPT), Autolus Therapeutics PLC (NASDAQ: AUTL) and Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT).

More news about: NetworkNewsWire


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.